BROADCASTS.com

This week, the top managed care news included a new proposal from CMS that insurers warn will cause confusion; a new review examines the prevalence and cost of chronic conditions in Medicaid; and a study finds 42% of all new US cancer cases in 2014 were due to potentially modifiable exposures.\n\nRead more about the stories in this podcast:\nHealth Insurers to CMS: Your Changes Will Confuse Consumers, Hurt Markets: www.ajmc.com/newsroom/health-insurers-to-cms-your-changes-will-confuse-consumers-hurt-markets\n\nIdentifying the Most Prevalent and Costly Chronic Conditions in Medicaid: www.ajmc.com/newsroom/identifying-the-most-prevalent-and-costly-chronic-conditions-in-medicaid\n\nLeading Diabetes Groups Publish Consensus Statement on "Beyond A1C" Measures to Guide FDA, Researchers: www.ajmc.com/newsroom/leading-diabetes-groups-publish-consensus-statement-on-beyond-a1c-measures-to-guide-fda-researchers\n\nSignificant Amount of Cancer Cases Attributable to Potentially Modifiable Risk Factors: www.ajmc.com/focus-of-the-week/significant-amount-of-cancer-cases-attributable-to-potentially-modifiable-risk-factors\n\nImpact of Health Reform on Young Adult Prescription Medication Utilization: www.ajmc.com/journals/issue/2017/2017-vol23-n11/impact-of-health-reform-on-young-adult-prescription-medication-utilization